Current Assets
Trading assets
Moderna Trading assets increased by 2.9% to $3.30B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 24.2%, from $4.35B to $3.30B. Over 5 years (FY 2020 to FY 2025), Trading assets shows an upward trend with a 10.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2018
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase suggests higher market activity or speculative positioning, while a decrease may indicate a shift toward more conservative liquidity management.
Detailed definition
Trading assets represent financial instruments acquired primarily for the purpose of selling them in the near term to ge...
Peer comparison
Common in financial services firms; less common in pure manufacturing, though present in captive finance arms.
Metric ID:
fin_trading_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.39B | $3.36B | $3.88B | $5.07B | $5.02B | $5.32B | $6.70B | $5.48B | $4.66B | $4.64B | $5.70B | $6.47B | $6.01B | $5.22B | $5.10B | $4.35B | $3.85B | $3.37B | $3.20B | $3.30B |
| QoQ Change | — | +40.6% | +15.6% | +30.6% | -0.8% | +5.9% | +25.9% | -18.1% | -15.0% | -0.4% | +22.8% | +13.6% | -7.1% | -13.1% | -2.4% | -14.6% | -11.5% | -12.5% | -5.0% | +2.9% |
| YoY Change | — | — | — | — | +110.5% | +58.6% | +72.6% | +8.2% | -7.3% | -12.8% | -14.9% | +18.1% | +29.0% | +12.5% | -10.5% | -32.8% | -35.9% | -35.4% | -37.2% | -24.2% |
Range$2.39B – $6.70B
CAGR+7.0%
Avg YoY Growth+6.2%
Median YoY Growth-8.9%
Trading assets at Other Companies
Frequently Asked Questions
- What is Moderna's trading assets?
- Moderna (MRNA) reported trading assets of $3.30B in Q1 2026.
- How has Moderna's trading assets changed year-over-year?
- Moderna's trading assets decreased by 24.2% year-over-year, from $4.35B to $3.30B.
- What is the long-term trend for Moderna's trading assets?
- Over 5 years (2020 to 2025), Moderna's trading assets has grown at a 10.1% compound annual growth rate (CAGR), from $1.98B to $3.20B.
- What does trading assets mean?
- Financial assets held for short-term trading purposes and recorded at current market value.